Physician profile
Kendra B Lee
NPI 1982600359
$792.24
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.74 · 2021: $28.64 · 2022: $395 · 2023: $138 · 2024: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.45 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $116.02 | 2022-2024 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $99.60 | 2020-2023 | Arexvy, Shingrix |
| Novo Nordisk INC | $89.85 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $72.90 | 2021-2024 | |
| Lilly USA, LLC | $64.06 | 2022-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.97 | 2022-2023 | Jardiance |
| Biohaven Pharmaceutical Holding Company Ltd. | $49.45 | 2022 | |
| Amgen INC. | $48.26 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $38.71 | 2022 | |
| Hologic Sales and Service, LLC | $36.23 | 2022-2024 | Thinprep 2000 Processor |
| Astellas Pharma US INC | $29.60 | 2024 | Veozah |
| Sanofi Pasteur INC. | $19.34 | 2022 | |
| Gilead Sciences, INC. | $17.81 | 2024 | |
| Abbvie INC. | $16.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.00 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.70 | 2020 | |
| Abbott Laboratories | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.